Management of Recurrent Ischemic Priapism: A Complex Condition with Devastating Consequences

    November 2014 in “ Sexual medicine reviews ”
    Michael P. Hoeh, Laurence A. Levine
    Image of study
    TLDR Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.
    The document reviewed various treatments for recurrent ischemic priapism (RIP), a complex condition with severe consequences. Ketoconazole (KTZ) showed promising results in 96% of patients, while PDE5 inhibitors were well-tolerated but had limited efficacy. Finasteride and other hormonal therapies had mixed results and significant side effects. Intracavernosal α-agonist therapy was effective for acute episodes but not for prevention. The review emphasized the need for well-tolerated, cost-effective preventive strategies and called for further research and clinical studies to improve management protocols.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 1000+ results

      community Finasteride is Good for Heart Health!

      in Research/Science  119 upvotes 11 months ago
      Finasteride, a hair loss and prostate drug, may also benefit heart health. Some users discuss the potential negative effects of DHT on the heart and the balance between hair loss treatments and heart health.

      community Physician here AMA – 30M oral Fin 1-1.25 mg daily

      in Update  47 upvotes 2 years ago
      Hair loss treatments, specifically the use of finasteride, microneedling and potentially oral minoxidil. People discussed their experiences with finasteride, its effects on sexual behaviors, as well as potential solutions such as tadalafil or using other growth factor signal peptides for hope in curing male pattern baldness.

      community Minoxidil alternative with a week long half-life? Why isn’t it possible?

      in Satire 2 years ago
      This conversation discussed the potential for a hair loss treatment alternative to minoxidil, with many users debating the economic and health implications of such an option. Some suggested that finasteride could be used as an alternative, while others argued that this would ultimately not benefit pharmaceutical companies due to their reliance on planned obsolescence.

      community So we’re just ok with taking a research chemical now?

      in Treatment  178 upvotes 3 years ago
      The conversation discusses the use of RU58841, a non-FDA approved research chemical for hair loss, with mixed opinions on its safety and effectiveness. Some users are willing to try it as a last resort after other treatments like Minoxidil and Finasteride failed, while others express concerns about potential long-term side effects and lack of official research.

    Similar Research

    5 / 1000+ results
      Hormonal Therapy in Dermatology

      research Hormonal Therapy in Dermatology

      24 citations, January 2001 in “Dermatologic clinics”
      Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.
      Acquired Scalp Alopecia: A Review

      research Acquired Scalp Alopecia: A Review

      37 citations, May 1999 in “Australasian Journal of Dermatology”
      Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.